News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Berger Mark Stanley
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/22/2023 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Genprex, Inc.|
Txns:
| Granted 245,000 shares
@ $0 |
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 46,667 options to buy
@ $0 |
|
| 07/16/2019 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.232, valued at
$92.8k
|
|
| 03/07/2019 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,500 shares
@ $0.6, valued at
$2.1k
|
|
| 07/17/2018 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.7829, valued at
$195.7k
|
|
| 03/19/2018 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Acquired 14,000 shares
@ $0.5, valued at
$7k
Acquired 3,500 options to buy
@ $0.6, valued at
$2.1k
Acquired 10,500 options to buy
@ $0.7, valued at
$7.4k
|
|
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|